(Q39725504)

https://api.crossref.org/works/10.1128/AAC.13.3.484

14 September 2017

Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics (English)

1 reference

https://api.crossref.org/works/10.1128/AAC.13.3.484

2 May 2022

main subject

Gram-negative bacteria

0 references

1 reference

2 May 2022

author name string

W. L. George

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A122524

2 May 2022

R. P. Lewis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A122524

2 May 2022

R. D. Meyer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A122524

2 May 2022

language of work or name

English

0 references

publication date

1 March 1978

1 reference

full work available at URL

14 September 2017

6

1 reference

based on heuristic

inferred from page(s)

https://europepmc.org/articles/PMC352268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A122524

https://europepmc.org/articles/PMC352268?pdf=render

2 May 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A122524

https://journals.asm.org/doi/pdf/10.1128/AAC.13.3.484

2 May 2022

1 reference

https://api.crossref.org/works/10.1128/AAC.13.3.484

Antimicrobial Agents and Chemotherapy

2 May 2022

published in

1 reference

14 September 2017

13

1 reference

14 September 2017

3

1 reference

14 September 2017

484-489

1 reference

Cefamandole: in vitro and clinical pharmacokinetics

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352268

Cefoxitin: clinical evaluation in thirty-eight patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352268

Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352268

Cefuroxime, a New Cephalosporin Antibiotic: Activity In Vitro

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352268

Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352268

Cefuroxime: human pharmacokinetics

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352268

The in vitro spectrum of the cephalosporins

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352268

Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352268

17 June 2018

Identifiers

DOI

10.1128/AAC.13.3.484

1 reference

14 September 2017

1 reference

PMC publication ID

352268

14 September 2017

1 reference

PMC publication ID

352268